In particular, while no concerns were risen about the need to perform RET analysis in a patient with MEN, it was observed that RET mutations are extremely rare in patients with CCH (0.03%), as reported by Scheuba et al. in 2009 [17]. The gene discussed is RET; the disease is columnar cell hyperplasia of the breast.